Novel Nanostructured Carbon Materials (NCMs) for Enhancing Targeted Delivery of Cancer Therapeutics

Novel Nanostructured Carbon Materials (NCMs) for Enhancing Targeted Delivery of Cancer Therapeutics portes grátis

Novel Nanostructured Carbon Materials (NCMs) for Enhancing Targeted Delivery of Cancer Therapeutics

Madkour, Loutfy H.

Taylor & Francis Ltd

03/2026

568

Dura

Inglês

9781041083498

Pré-lançamento - envio 15 a 20 dias após a sua edição

Descrição não disponível.
Foreword. Preface. Acknowledgment. About the author. Introduction. Summary. Chapter 1Recent Developments and Future Prospects In vitro and In vivo of CNTs Nanocarriers for-Targeted Drug Delivery System. Chapter 2 Carbon Nanotubes as Targeting Therapeutic Arsenal for Blood Brain Cancer Tumors Diseases-Based Novel Drug Delivery Platforms. Chapter 3 Carbon Nanomaterials as Emerging Nanocarriers for the Anti-Cancer Targeting Drug Delivery Doxorubicin: Improved Novel Cancer Therapy Technologies. Chapter 4 Novel Technologies Toward Intervention Carbon Family-Based Nanomaterials for Detection, Diagnosis and Cancer Therapeutics. Chapter 5 Pharmacokinetics, Biodistribution and Intracellular Energy Metabolism Aspects of Carbon Nanomaterials: Improving Novel Outcomes of Functionalization for Biomedical Applications. Chapter 6 Cytotoxicity Profile of Carbon Nanomaterials as an Effective Anticancer Drug Carriers. Chapter 7 Novel Tumor-Targeting Drug Delivery Systems Based- Carbon Nanomaterials in Cancer Treatment. Chapter 8 Carbon-Based Nanomaterials (CBNMs) as Emerging Platform for Anticancer Nanotherapy: Novel Strategy and Future Prospects. Chapter 9 Recent Advancements of Carbon Dots Strategy Based Effective Novel Photosensitizers and Anticancer Drug Delivery System. References. Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
carbon nanotube carriers;supramolecular self-assembly;stimuli-responsive nanomedicine;blood brain barrier delivery;cytotoxicity assessment;functionalization strategies;advanced cancer nanotherapy platforms